These results indicate that XA5508 can activate and increase the infiltration of CD4+ T cells and CD8+ T cells in the tumor, reduce the number of M2-type macrophages, and reverse the immunosuppressive TME in HCC. The gene discussed is CD8A; the disease is hepatocellular carcinoma.